Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives

Overall survival of gastric cancer remains low, as patients are often diagnosed with advanced stage disease. In this review, we give an overview of current research on biomarkers in gastric cancer and their implementation in treatment strategies. The HER2-targeting trastuzumab is the first molecular...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nadja Niclauss, Ines Gütgemann, Jonas Dohmen, Jörg C. Kalff, Philipp Lingohr
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d9b7fe0ecc1249cd8def507e944b250c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares